Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Cohen, Clemens D ^a,b   Lindenmeyer, Maja T ^a,b   Eichinger, Felix ^c   Hahn, Alexander ^d   Seifert, Martin ^d   Moll, Anton G ^a,b   Schmid, Holger ^b   Kiss, Eva ^e   Gröne, Elisabeth ^e   Grönes, Hermann Josef ^e   Kretzler, Matthias ^c   Werner, Thomas ^d   Nelson, Peter J ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Genomatix GmbH   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

WNT PROTEIN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; SCLEROPROTEIN; SOCS2 PROTEIN, HUMAN; SPON2 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CROSS HYBRIDIZATION; DIABETIC NEPHROPATHY; DNA MICROARRAY; FALSE POSITIVE RESULT; GENE CONTROL; GENETIC DATABASE; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INTERMETHOD COMPARISON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; DISEASE COURSE; DNA PROBE; GENETICS; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DNA PROBES; EXTRACELLULAR MATRIX PROTEINS; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 51849115165     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002937     Document Type: Article

References (27)

1. Schena FP, Gesualdo L (2005) Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16 Suppl 1: S30-33.
2. Roster C, Wolf G (2008) The rote of chemokines and chemokine receptors in diabetic nephropathy. Front Biosci 13: 944-955.
3. Navarro-Gonzalez JF, Mora-Fernandez C (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19: 433-442.
4. Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, et al. (2006) Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003.
5. Lindenmeyer MT, Kretzler M, Boucherot A, Berra S, Yasuda Y, et al. (2007) Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 18: 1765-1776.
6. Dai M, Wang P, Boyd AD, Kostov G, Athey B, et al. (2005) Evolving gene/ transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175.
7. Elo LL, Lahti L, Skottman H, Kylaniemi M, Lahesmaa R, et al. (2005) Integrating probe-level expression changes across generations of Affymetrix arrays. Nucleic Acids Res 33: e193.
8. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
9. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
10. Galkina E, Ley K (2006) Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 17: 368-377.
11. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, et al. (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355: 241-250.
12. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323.
13. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30.
14. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner V (1999) beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155: 1033-1038.
15. Pawitan Y, Michiels S, Koscielny S, Gusnanto A, Ploner A (2005) False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics 21: 3017-3024.
16. Lu J, Lee JC, Salit ML, Cam MC (2007) Transcript-based redefinition of grouped oligonucleotide probe sets using AceView: high-resolution annotation for microarrays. BMC Bioinformatics 8: 108.
17. Schedl A (2007) Renal abnormalities and their developmental origin. Nat Rev Genet 8: 791-802.
18. Catania JM, Chen G, Parrish AR (2007) Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 292: F905-911.
19. McLennan SV, Kelly DJ, Schache M, Waltham M, Dy V, et al. (2007) Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy? Kidney Int 72: 481-488.
20. Breyer MD, Bottinger E, Brosius FC, Coffman TM, Fogo A, et al. (2005) Diabetic nephropathy: of mice and men. Adv Chronic Kidney Dis 12: 128-145.
21. Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
22. Cohen CD, Frach K, Schlondorff D, Kretzler M (2002) Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 61: 133-140.
23. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
24. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
25. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA (2003) Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70.
26. Schmid H, Cohen CD, Henger A, Irrgang S, Schlondorff D, et al. (2003) Validation of endogenous controls for gene expression analysis in microdissected human renal biopsies. Kidney Int 64: 356-360.
27. Henger A, Kretzler M, Doran P, Bonrouhi M, Schmid H, et al. (2004) Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int 65: 904-917.